Infusion therapies for Parkinson’s disease : where are we in 2025?
(2025) In Expert Opinion on Drug Delivery
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/e0b15cda-4c6a-4224-bd46-022d57a9f949
- author
- Rigon, Leonardo
; Fogliano, Carmelo
; Odin, Per
LU
and Antonini, Angelo
- organization
- publishing date
- 2025
- type
- Contribution to journal
- publication status
- epub
- subject
- keywords
- apomorphine, device-aided therapies, foslevodopa, infusion therapies, levodopa-carbidopa intestinal gel, levodopa-entacapone-carbidopa intestinal gel, Parkinson’s disease, subcutaneous levodopa
- in
- Expert Opinion on Drug Delivery
- publisher
- Taylor & Francis
- external identifiers
-
- scopus:105019626846
- pmid:41105663
- ISSN
- 1742-5247
- DOI
- 10.1080/17425247.2025.2577710
- language
- English
- LU publication?
- yes
- id
- e0b15cda-4c6a-4224-bd46-022d57a9f949
- date added to LUP
- 2026-01-27 15:35:42
- date last changed
- 2026-01-28 02:24:35
@article{e0b15cda-4c6a-4224-bd46-022d57a9f949,
author = {{Rigon, Leonardo and Fogliano, Carmelo and Odin, Per and Antonini, Angelo}},
issn = {{1742-5247}},
keywords = {{apomorphine; device-aided therapies; foslevodopa; infusion therapies; levodopa-carbidopa intestinal gel; levodopa-entacapone-carbidopa intestinal gel; Parkinson’s disease; subcutaneous levodopa}},
language = {{eng}},
publisher = {{Taylor & Francis}},
series = {{Expert Opinion on Drug Delivery}},
title = {{Infusion therapies for Parkinson’s disease : where are we in 2025?}},
url = {{http://dx.doi.org/10.1080/17425247.2025.2577710}},
doi = {{10.1080/17425247.2025.2577710}},
year = {{2025}},
}